| Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours H Yao, J Lan, C Li, H Shi, JP Brosseau, H Wang, H Lu, C Fang, Y Zhang, ... Nature biomedical engineering 3 (4), 306-317, 2019 | 316 | 2019 |
| Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer Q Dou, HN Chen, K Wang, K Yuan, Y Lei, K Li, J Lan, Y Chen, Z Huang, ... Cancer research 76 (15), 4457-4469, 2016 | 238 | 2016 |
| HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity H Wang, H Yao, C Li, H Shi, J Lan, Z Li, Y Zhang, L Liang, JY Fang, J Xu Nature chemical biology 15 (1), 42-50, 2019 | 212 | 2019 |
| Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking R Liu, J Li, T Zhang, L Zou, Y Chen, K Wang, Y Lei, K Yuan, Y Li, J Lan, ... Autophagy 10 (7), 1241-1255, 2014 | 176 | 2014 |
| Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux K Wang, T Zhang, Y Lei, X Li, J Jiang, J Lan, Y Liu, H Chen, W Gao, N Xie, ... Autophagy 14 (2), 269-282, 2018 | 104 | 2018 |
| Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma J Jiang, L Zhang, H Chen, Y Lei, T Zhang, Y Wang, P Jin, J Lan, L Zhou, ... Autophagy 16 (1), 106-122, 2020 | 101 | 2020 |
| PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation N Xie, K Yuan, L Zhou, K Wang, HN Chen, Y Lei, J Lan, Q Pu, W Gao, ... Autophagy 12 (9), 1507-1520, 2016 | 72 | 2016 |
| CPX targeting DJ-1 triggers ROS-induced cell death and protective autophagy in colorectal cancer J Zhou, L Zhang, M Wang, L Zhou, X Feng, L Yu, J Lan, W Gao, C Zhang, ... Theranostics 9 (19), 5577, 2019 | 68 | 2019 |
| Redox regulation of microRNAs in cancer J Lan, Z Huang, J Han, J Shao, C Huang Cancer Letters 418, 250-259, 2018 | 46 | 2018 |
| Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling K Yuan, J Lan, L Xu, X Feng, H Liao, K Xie, H Wu, Y Zeng Molecular Cancer 21 (1), 105, 2022 | 40 | 2022 |
| A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions H Yao, C Li, F He, T Song, JP Brosseau, H Wang, H Lu, C Fang, H Shi, ... RSC Chemical Biology 2 (1), 192-205, 2021 | 32 | 2021 |
| Mechanisms of resistance to checkpoint blockade therapy H Shi, J Lan, J Yang Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms …, 2020 | 31 | 2020 |
| Thiol‐based redox proteomics in cancer research K Yuan, Y Liu, HN Chen, L Zhang, J Lan, W Gao, Q Dou, EC Nice, ... Proteomics 15 (2-3), 287-299, 2015 | 29 | 2015 |
| Pathology, proteomics and the pathway to personalised medicine P Jin, J Lan, K Wang, MS Baker, C Huang, EC Nice Expert review of proteomics 15 (3), 231-243, 2018 | 23 | 2018 |
| The influence of COVID-19 on colorectal cancer was investigated using bioinformatics and systems biology techniques Y Song, T Huang, H Pan, A Du, T Wu, J Lan, X Zhou, Y Lv, S Xue, K Yuan Frontiers in Medicine 10, 2023 | 3 | 2023 |
| Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma X Zhou, T Huang, H Pan, A Du, T Wu, J Lan, Y Song, Y Lv, F He, K Yuan Plos one 19 (4), e0300441, 2024 | | 2024 |
| Bioinformatics Approaches to Determine the Effect of SARS-CoV-2 Infection on Patients with Intrahepatic Cholangiocarcinoma X Zhou, T Huang, H Pan, J Lan, T Wu, A Du, Y Song, Y Lv, K Yuan bioRxiv, 2023.01. 04.522709, 2023 | | 2023 |
| Palmitoylation is critically required for cancer intrinsic PD-1 expression and functions H Yao, C Li, JP Brosseau, H Wang, H Lu, C Fang, H Shi, J Lan, J Xu bioRxiv, 625483, 2019 | | 2019 |
| Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours (vol 3, pg 306, 2019) H Yao, J Lan, C Li, H Shi, JP Brosseau, H Wang, H Lu, C Fang, Y Zhang, ... Nature Biomedical Engineering 3 (5), 414-414, 2019 | | 2019 |
